Search Results - "Jordaens, L J L M"

The Entirely Subcutaneous Implantable Cardioverter-Defibrillator: Initial Clinical Experience in a Large Dutch Cohort by OLDE NORDKAMP, Louise R. A, DABIRI ABKENARI, Lara, BOERSMA, Lucas V. A, MAASS, Alexander H, DE GROOT, Joris R, VAN OOSTROM, Antonie J. H. H. M, THEUNS, Dominic A. M. J, JORDAENS, Luc J. L. M, WILDE, Arthur A. M, KNOPS, Reinoud E

“…The purpose of the study was to evaluate the efficacy and safety of the entirely subcutaneous implantable cardioverter-defibrillator (S-ICD). A new entirely…”
Get full text

Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score by Kraaier, Karin, Scholten, Marcoen F, Tijssen, Jan G P, Theuns, Dominic A M J, Jordaens, Luc J L M, Wilde, Arthur A M, van Dessel, Pascal F H M

“…To reduce sudden cardiac death, implantable cardioverter-defibrillators (ICDs) are indicated in patients with ischaemic and non-ischaemic dilated…”
Get full text

Early markers of atrial fibrillation recurrence after pulmonary vein isolation by Lanters, Eva A. H., Teuwen, Christophe P., Hokken, Thijmen, Rohde, Sofie, Haitsma, David B., Zijlstra, Felix, Jordaens, Luc J. L. M., Groot, Natasja M. S.

“…Background Postprocedural atrial extrasystole (AES) frequency predicts atrial fibrillation (AF) recurrence after pulmonary vein isolation (PVI) in patients…”
Get full text

Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis by Schinkel, Arend F L, Vriesendorp, Pieter A, Sijbrands, Eric J G, Jordaens, Luc J L M, ten Cate, Folkert J, Michels, Michelle

“…Previous observational studies demonstrated that patients with hypertrophic cardiomyopathy at risk for sudden cardiac death (SCD) may benefit from implantable…”
Get full text

Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy by Olde Nordkamp, Louise R.A., MD, Knops, Reinoud E., MD, Bardy, Gust H., MD, Blaauw, Yuri, MD, PhD, Boersma, Lucas V.A., MD, PhD, Bos, Johannes S., MD, PhD, Delnoy, Peter Paul H.M., MD, PhD, van Dessel, Pascal F.H.M., MD, PhD, Driessen, Antoine H.G., MD, de Groot, Joris R., MD, PhD, Herrman, Jean Paul R., MD, PhD, Jordaens, Luc J.L.M., MD, PhD, Kooiman, Kirsten M., CCDS, Maass, Alexander H., MD, PhD, Meine, Mathias, MD, PhD, Mizusawa, Yuka, MD, Molhoek, Sander G., MD, PhD, van Opstal, Jurjen, MD, PhD, Tijssen, Jan G.P., PhD, Wilde, Arthur A.M., MD, PhD

“…Background Implantable cardioverter-defibrillators (ICDs) are widely used to prevent fatal outcomes associated with life-threatening arrhythmic episodes in a…”
Get full text

Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications by Vriesendorp, Pieter A., MD, Schinkel, Arend F.L., MD, PhD, Van Cleemput, Johan, MD, PhD, Willems, Rik, MD, PhD, Jordaens, Luc J.L.M., MD, PhD, Theuns, Dominic A.M.J., PhD, van Slegtenhorst, Marjon A., MD, PhD, de Ravel, Thomy J., MD, PhD, ten Cate, Folkert J., MD, PhD, Michels, Michelle, MD, PhD

“…Background Sudden cardiac death (SCD) is the most devastating complication of hypertrophic cardiomyopathy (HCM), but this can be prevented by an implantable…”
Get full text

Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: Rationale and design of the Defibrillator After Primary Angioplasty (DAPA) Trial by Ottervanger, Jan Paul, Ramdat Misier, Anand R., Zijlstra, Felix, Schalij, Martin J., Wever, Eric, Jordaens, Luc J.L.M., Henriques, Jose P.S., de Boer, Menko-Jan, Robbe, Hindrik W.J., Wellens, Hein J.J.

“…It has been shown that an implantable cardioverter defibrillator (ICD) may be beneficial when added to optimal drug treatment in patients with reduced left…”
Get full text

Prevention of inappropriate therapy in implantable cardioverter-defibrillators: Results of a prospective, randomized study of tachyarrhythmia detection algorithms by THEUNS, Dominic A. M. J, KLOOTWIJK, A. Peter J, GOEDHART, Dick M, JORDAENS, Luc J. L. M

“…The purpose of this randomized study was to investigate the performance of single- and dual-chamber tachyarrhythmia detection algorithms. A proposed benefit of…”
Get full text

Usefulness of remote magnetic navigation for ablation of ventricular arrhythmias originating from outflow regions by Schwagten, B. K. R., Szili-Torok, T., Rivero-Ayerza, M., Jessurun, E., Valk, S., Jordaens, L. J. L. M.

“…Monomorphic ventricular tachycardia (VT) and symptomatic monomorphic PVCs originating from the region of the right and left outflow tracts are increasingly…”
Get full text

Recommendations and cardiological evaluation of athletes with arrhythmias: Part 2 by Hoogsteen, J, Bennekers, J H, van der Wall, E E, van Hemel, N M, Wilde, A A M, Crijns, H J G M, Gorgels, A P M, Smeets, J L R M, Hauer, R N W, Jordaens, J L M, Schalij, M J

“…Confronted with a competitive or recreational athlete, the physician has to discriminate between benign, paraphysiological and pathological arrhythmias. Benign…”
Get full text

Recommendations and cardiological evaluation of athletes with arrhythmias: Part 1 by Hoogsteen, J, Bennekers, J H, van der Wall, E E, van Hemel, N M, Wilde, A A M, Crijns, H J G M, Gorgels, A P M, Smeets, J L R M, Hauer, R N W, Jordaens, J L M, Schalij, M J

“…Besides the consensus meeting in Amersfoort in 1988 and the Bethesda conference in 1994 recommendations are not available in the Netherlands for screening and…”
Get full text

Recommendations for pacemaker implantation for the treatment of atrial tachyarrhythmias and resynchronisation therapy for heart failure: A report from the task force on pacemaker indications of the Dutch Working Group on Cardiac Pacing by van Hemel, N M, Dijkman, B, de Voogt, W G, Beukema, W P, Bosker, H A, de Cock, C C, Jordaens, L J L M, van Gelder, I C, van Gelder, L M, van Mechelen, R, Ruiter, J H, Sedney, M I, Slegers, L C

“…Today, new pacing algorithms and stimulation methods for the prevention and interruption of atrial tachyarrhythmias can be applied on patients who need…”
Get full text

Clinical benefit, survival and adverse events in patients with implantable cardioverter defibrillators: the initial Rotterdam experience by Theuns, D A M J, Klootwijk, A P J, Kimman, G P, Simoons, M L, Roelandt, J R T C, Jordaens, L J L M

“…The implantable cardioverter defibrillator (ICD) has become a widely accepted therapy for patients with severe life-threatening ventricular tachyarrhythmias…”
Get full text